Europe Cancer Biomarkers Market Share

Statistics for the 2023 & 2024 Europe Cancer Biomarkers market share, created by Mordor Intelligence™ Industry Reports. Europe Cancer Biomarkers share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Europe Cancer Biomarkers Industry

The European cancer biomarkers market is highly competitive and consists of a few major players. Some companies currently dominating the market include Abbott Laboratories Inc., Agilent Technologies, Ambry Genetics, Biomerieux, Celera Corporation (Quest Diagnostics), F. Hoffmann-La Roche Ltd, Hologic Inc., Illumina Inc., and Thermo Fisher Scientific. Furthermore, some of the major market players, such as Novartis and Gilead in cancer therapy, are from Europe, one of the factors boosting the R&D activities in the region.

Europe Cancer Biomarkers Market Leaders

  1. Abbott Laboratories Inc

  2. F. Hoffmann-La Roche Ltd

  3. Illumina Inc

  4. Thermo Fisher Scientific

  5. Biomerieux

*Disclaimer: Major Players sorted in no particular order

Europe Cancer Biomarkers Market Analysis

Europe Cancer Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)